Refine
Has Fulltext
- yes (45)
Is part of the Bibliography
- yes (45)
Year of publication
- 2020 (45) (remove)
Document Type
- Journal article (44)
- Doctoral Thesis (1)
Language
- English (45) (remove)
Keywords
- multiple myeloma (9)
- relapse (4)
- B cells (3)
- refractory (3)
- 18F-FDG PET/CT (2)
- cancer (2)
- inflammation (2)
- management (2)
- mortality (2)
- 11C-Methionine PET/CT (1)
- 3D culture (1)
- 68Ga-Pentixafor PET/CT (1)
- AKT-signaling (1)
- ALiOS (1)
- ASE formula (1)
- Adaptive cell transfer (1)
- Aspergillus fumigatus (1)
- Aspergillus sp. (1)
- Autologous hematopoietic stem cell transplantation (1)
- B cell (1)
- CAR T cell (1)
- CAR T cells (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- CCS (1)
- CD38 (1)
- CMV reactivation (1)
- COX2 expression (1)
- Candida sp. (1)
- Coronavirus Disease 2019 (1)
- Donor lymphocytes (1)
- EGFR (1)
- HB-EGF (1)
- HGF (1)
- HNSCC (1)
- Hämostase (1)
- Infectious complications (1)
- JCV (1)
- KRAS (1)
- MAPKAPK2 (1)
- MEK/ERK-signaling (1)
- MOR202 (1)
- MYC (1)
- Megakaryozyt (1)
- Met (1)
- Myeloma (1)
- NAFLD (1)
- NASH (1)
- NGS (1)
- NLRP3 (1)
- NRF2 (1)
- PD-L1 (1)
- PML (1)
- POU6F2-AS2 (1)
- Pom‐PAD‐Dara (1)
- Prodigy (1)
- Radiochemotherapy (1)
- Rectal cancer (1)
- Rhizopus arrhizus (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Surgery (1)
- Systemic sclerosis (1)
- T cell (1)
- T cells (1)
- TLR agonists (1)
- TNFSF14 (1)
- TNFSF4 (1)
- TSLP (1)
- Tdp-43 (1)
- Teichholz formula (1)
- Time interval (1)
- VCE (1)
- Western diet (1)
- Zink (1)
- acute lymphoblastic leukaemia (1)
- acute respiratory distress syndrome (1)
- adalimumab (1)
- adverse events (1)
- amplicon sequencing (1)
- amyotrophic lateral sclerosis (1)
- anticoagulation (1)
- antithrombotic therapy (1)
- anxiety (1)
- atrial fibrillation (1)
- autoimmune encephalitis (1)
- autoimmunity (1)
- autologous stem cell transplantation (1)
- axonal transcriptome (1)
- binding (1)
- blinatumomab (1)
- bone (1)
- bone marrow angiogenesis (1)
- bridging (1)
- cancer vaccines (1)
- capture (1)
- carfilzomib (1)
- cfRNA (1)
- chimeric antigen receptor (1)
- clinical trial (1)
- colonoscopy (1)
- common variable immunodeficiency (1)
- complications (1)
- corticosteroids (1)
- cytokines (1)
- daratumumab (1)
- ddPCR (1)
- definition (1)
- dendritic cells (1)
- discharge definition (1)
- donor-cell leukemia (1)
- drug screening (1)
- early detection (1)
- echocardiography (1)
- endothelial cells (1)
- extramedullary disease (1)
- fluorescence (1)
- fungal aerosolization (1)
- fungal infection (1)
- fungal infections (1)
- galactomannan (1)
- gene (1)
- genetic susceptibility (1)
- growth differentiation factor 15 (1)
- head and neck cancer (1)
- helicase (1)
- hematologic malignancies (1)
- hematological malignancies (1)
- hemodialysis (1)
- immune response (1)
- immune therapy (1)
- immunity (1)
- immuno-oncology (1)
- immunotherapeutics (1)
- immunotherapy (1)
- incidence (1)
- inflammasome (1)
- inflammation-induced tissue demage (1)
- interacts (1)
- interleukin 1 (1)
- interleukin 18 (1)
- invasive aspergillosis (1)
- kinease (1)
- left ventricular hypertrophy (1)
- left ventricular mass index (1)
- lenalidomide (1)
- lentiviral transduction (1)
- life-threatening side-effects (1)
- liquid biopsy (1)
- low molecular heparin (1)
- lymphocytes (1)
- mantle cell lymphoma (1)
- mechanosensing (1)
- mechanotransduction (1)
- melanoma malignancy (1)
- memory B cells (1)
- metabolic tumor volume (MTV) (1)
- methionine (1)
- molecular diagnosis (1)
- monocytes (1)
- multiplex PCR (1)
- muscle (1)
- music (1)
- myokines (1)
- nOAC (1)
- natural killer cell (1)
- newly diagnosed (1)
- nicotinamide (1)
- novel therapies (1)
- nuclear receptors (1)
- nucleotide excision repair (1)
- obinutuzumab (1)
- oral anticoagulants (1)
- organoids (1)
- osteokines adaptation (1)
- pancreatectomy (1)
- pathophysiology (1)
- pattern (1)
- personalised medicine (1)
- porcine large animal model (1)
- postoperative bleeding (1)
- pre-clinical models (1)
- primary immunodeficiencies (1)
- progression (1)
- prostaglandin E2 (1)
- pulmonary immune response (1)
- radiogenomics (1)
- recognition (1)
- relaxation (1)
- rheumatoid arhritis (1)
- safety (1)
- serum biomarkers (1)
- small bowel bleeding (1)
- smoldering myeloma (1)
- stem cell transplantation (1)
- stress level (1)
- subunit (1)
- sulfur (1)
- superior (1)
- surgical care (1)
- t-lymphocytes (1)
- thromboembolism (1)
- tocilizumab (IL-6 inhibitor) (1)
- total lesion glycolysis (TLG) (1)
- total lesion methionine uptake (TLMU) (1)
- toxicity (1)
- transactivation (1)
- tumor microenvironment (1)
- tumor-infiltrating (1)
- tumor-specific CD8+ T cells (1)
- tumor‐specific antigen (1)
- venetoclax (1)
- video capsule endoscopy (1)
- warfarin interruption (1)
Institute
- Medizinische Klinik und Poliklinik II (45) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 733297 (2)
- 19-COP-0031 (1)
- 641458 (1)
- 754658 (1)
- 847507 (1)
- 853988 (1)
- EU-1650-0006 (1)
Protein inclusions containing the RNA-binding protein TDP-43 are a pathological hallmark of amyotrophic lateral sclerosis and other neurodegenerative disorders. The loss of TDP-43 function that is associated with these inclusions affects post-transcriptional processing of RNAs in multiple ways including pre-mRNA splicing, nucleocytoplasmic transport, modulation of mRNA stability and translation. In contrast, less is known about the role of TDP-43 in axonal RNA metabolism in motoneurons. Here we show that depletion of Tdp-43 in primary motoneurons affects axon growth. This defect is accompanied by subcellular transcriptome alterations in the axonal and somatodendritic compartment. The axonal localization of transcripts encoding components of the cytoskeleton, the translational machinery and transcripts involved in mitochondrial energy metabolism were particularly affected by loss of Tdp-43. Accordingly, we observed reduced protein synthesis and disturbed mitochondrial functions in axons of Tdp-43-depleted motoneurons. Treatment with nicotinamide rescued the axon growth defect associated with loss of Tdp-43. These results show that Tdp-43 depletion in motoneurons affects several pathways integral to axon health indicating that loss of TDP-43 function could thus make a major contribution to axonal pathomechanisms in ALS.